These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 23914652)

  • 1. Tenecteplase for stroke salvage therapy--extending the therapeutic window via CT based selection.
    Kamran S; Muzammil SM; Kamal AK
    J Pak Med Assoc; 2013 Mar; 63(3):406-7. PubMed ID: 23914652
    [No Abstract]   [Full Text] [Related]  

  • 2. NIHSS/EIC mismatch explains the >1/3 MCA conundrum.
    Grotta J
    Stroke; 2003 Sep; 34(9):e148-9; author reply e148-9. PubMed ID: 12933969
    [No Abstract]   [Full Text] [Related]  

  • 3. Reperfusion strategy for simultaneous ST-segment elevation myocardial infarction and acute ischemic stroke within a time window.
    González-Pacheco H; Méndez-Domínguez A; Vieyra-Herrera G; Azar-Manzur F; Meave-González A; Rodríguez-Zanella H; Martínez-Sánchez C
    Am J Emerg Med; 2014 Sep; 32(9):1157.e1-4. PubMed ID: 24703066
    [No Abstract]   [Full Text] [Related]  

  • 4. Does clinical-CT 'mismatch' predict early response to treatment with recombinant tissue plasminogen activator?
    Choi JY; Pary JK; Alexandrov AV; Molina CA; Garami Z; Malkoff MD; Rubiera M; Shaltoni HM; Moye LA; Grotta JC
    Cerebrovasc Dis; 2006; 22(5-6):384-8. PubMed ID: 16888380
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of acute ischemic stroke: Part I: recanalization strategies.
    Broderick JP; Hacke W
    Circulation; 2002 Sep; 106(12):1563-9. PubMed ID: 12234965
    [No Abstract]   [Full Text] [Related]  

  • 6. Therapeutic applications of transcranial ultrasound devices.
    Alexandrov AV
    Expert Rev Med Devices; 2007 Jan; 4(1):1-3. PubMed ID: 17187465
    [No Abstract]   [Full Text] [Related]  

  • 7. Early ischemic change on CT versus diffusion-weighted imaging for patients with stroke receiving intravenous recombinant tissue-type plasminogen activator therapy: stroke acute management with urgent risk-factor assessment and improvement (SAMURAI) rt-PA registry.
    Nezu T; Koga M; Nakagawara J; Shiokawa Y; Yamagami H; Furui E; Kimura K; Hasegawa Y; Okada Y; Okuda S; Kario K; Naganuma M; Maeda K; Minematsu K; Toyoda K
    Stroke; 2011 Aug; 42(8):2196-200. PubMed ID: 21719764
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison of Computed Tomography perfusion-guided and time-guided endovascular treatments for patients with acute ischemic stroke.
    Hassan AE; Zacharatos H; Rodriguez GJ; Vazquez G; Miley JT; Tummala RP; Suri MF; Taylor RA; Qureshi AI
    Stroke; 2010 Aug; 41(8):1673-8. PubMed ID: 20616318
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Intravenous thrombolysis in the treatment of acute ischaemic stroke: 3, 4.5, or 6 hours?].
    Kwieciński H
    Neurol Neurochir Pol; 2009; 43(3):213-5. PubMed ID: 19618303
    [No Abstract]   [Full Text] [Related]  

  • 10. Intravenous recombinant tissue plasminogen activator administered after 3 h following onset of ischaemic stroke: a metaanalysis.
    Maiser SJ; Georgiadis AL; Suri MF; Vazquez G; Lakshminarayan K; Qureshi AI
    Int J Stroke; 2011 Feb; 6(1):25-32. PubMed ID: 21205237
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Questions about authorisation of alteplase for ischaemic stroke.
    Shinton R
    Lancet; 2014 Aug; 384(9944):659-60. PubMed ID: 25152265
    [No Abstract]   [Full Text] [Related]  

  • 12. Thrombolysis for acute stroke in patient with systemic lupus erythematosus: A case report.
    Majdak MR; Vuletić V
    J Neurol Sci; 2016 Feb; 361():7-8. PubMed ID: 26810507
    [No Abstract]   [Full Text] [Related]  

  • 13. A drip in time worked just fine: Thrombolysis in stroke with recent myocardial infarction.
    Adukia SA; Dash GK; Patanvadiya AH
    Neurol India; 2019; 67(2):540-541. PubMed ID: 31085875
    [No Abstract]   [Full Text] [Related]  

  • 14. Tenecteplase for acute ischemic stroke.
    Lyden P
    Int J Stroke; 2011 Dec; 6(6):509-10. PubMed ID: 22111795
    [No Abstract]   [Full Text] [Related]  

  • 15. How Patient Demographics, Imaging, and Beliefs Influence Tissue-Type Plasminogen Activator Use: A Survey of North American Neurologists.
    Shamy MC; Pugliese M; Meisel K; Rodriguez R; Kim AS; Stahnisch FW; Smith EE
    Stroke; 2016 Aug; 47(8):2051-7. PubMed ID: 27364532
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The stroke care revolution.
    Lancet Neurol; 2015 Apr; 14(4):341. PubMed ID: 25752414
    [No Abstract]   [Full Text] [Related]  

  • 17. Further randomized controlled trials of tPA within 3 hours are required-not!
    Lyden PD
    Stroke; 2001 Nov; 32(11):2709-10. PubMed ID: 11692041
    [No Abstract]   [Full Text] [Related]  

  • 18. When is enough enough?
    Donnan GA; Davis SM
    Stroke; 2001 Nov; 32(11):2710-1. PubMed ID: 11692042
    [No Abstract]   [Full Text] [Related]  

  • 19. Tenecteplase versus alteplase for acute ischemic stroke.
    González RG
    N Engl J Med; 2012 Jul; 367(3):275-6; author reply 276. PubMed ID: 22808969
    [No Abstract]   [Full Text] [Related]  

  • 20. Should more patients with acute ischaemic stroke receive thrombolytic treatment?
    Wardlaw JM; Sandercock PA; Murray V
    BMJ; 2009 Nov; 339():b4584. PubMed ID: 19906748
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.